Synbiobeta will engage a conversation on sector-specific progress ranging from research-enabling tools to low-cost DNA synthesis, scale-up of industrial biotech platforms to the growing importance of the organism industry.
Who Should Attend?
Startups: Meet the investors ready to fund your team.
Industry: Network with industry leaders and potential partners.
Investors: Meet the new startups on the scene.
Partners & Tech Scouts: Learn about the latest technology in the field.
Academics, Students & Biohackers: Follow the path to commercializing your IP.
Speakers
J. Craig Venter
Spencer Adler SynBio Investors
Omri Amirav-Drory Genome Compiler
Jamie Bacher Pareto Biotechnologies
Justin Bingham SGI-DNA
Mark Bünger Lux Research
Blake Byers Google Ventures
Rob Carlson Biodesic
Brandon Chen Genomatica
Elizabeth Clarke Industrial Microbes
Adam Clore Integrated DNA Technologies
Denver Dale On-Point Capital
Stephen del Cardayre
Douglas Densmore Lattice Automation
Jeffrey Dietrich Lygos
Tim Fell Synthace
Michael Fero TeselaGen
Ian Fotheringham Ingenza
Itschak Friedman LionBird
Edward Green Green Biologics Ltd
Eli Groban Intrexon
Claes Gustafsson DNA2.0
Rachel E. Haurwitz Caribou Biosciences
Keira Havens Revolution Bioengineering
Austen Heinz Cambrian Genomics
Alfred Ho Morph Bioinformatics
Max Hodak Transcriptic
Jeffrey Hung GenScript
Elizabeth Iorns Science Exchange
Jason Kakoyiannis Bioscentric
Kef Kasdin Proterro
Michael Koepke LanzaTech
Mike Koeris Sample6
Devin Leake Gen9
Scott Nolan Founders Fund
Matt Ocko Data Collective
Jonny Ohlson Touchlight Genetics
Christian Olsen Biomatters
Megan Palmer Synberc
Una Ryan Bay Area BioEconomy Initiative
Zach Serber Zymergen
Reshma Shetty Ginkgo BioWorks
Steve Somers Vigon International
Sajith Wickramasekara Benchling
Dan Widmaier Refactored Materials
Michael Yates Algenuity
To register click here.
0 comments:
Post a Comment